TVARDI THERAPEUTICS, INC. Additional Paid in Capital, Common Stock
TVARDI THERAPEUTICS, INC. (TVRD) had Additional Paid in Capital, Common Stock of $752.44 million as of 2025-03-31, per its 10-Q filed 2025-05-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent › Additional Paid in Capital
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2025-05-13
- 2025-03-31: Additional Paid in Capital, Common Stock $752.44M.
- 2024-12-31: Additional Paid in Capital, Common Stock $751.02M; Additional Paid in Capital, Common Stock as first filed $751.01M.
- 2024-09-30: Additional Paid in Capital, Common Stock $748.61M.
- 2024-06-30: Additional Paid in Capital, Common Stock $747.12M.
| Period end | Additional Paid in Capital, Common Stock | Additional Paid in Capital, Common Stock as first filed |
|---|---|---|
| 2025-03-31 | $752.44M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $751.02M 10-Q · filed 2025-05-13 | $751.01M 10-K · filed 2025-03-11 |
| 2024-09-30 | $748.61M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $747.12M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $745.38M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $742.09M 10-K · filed 2025-03-11 | $742.04M 10-K · filed 2024-03-06 |
| 2023-09-30 | $738.43M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $733.98M 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $730.54M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $726.63M 10-K · filed 2024-03-06 | |
| 2022-09-30 | $722.81M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $719.13M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $714.29M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $708.59M 10-K · filed 2023-03-06 | |
| 2021-09-30 | $699.48M 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $649.78M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $646.01M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $641.20M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $598.66M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $594.96M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $590.14M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $587.22M 10-K · filed 2021-02-25 | |
| 2019-09-30 | $583.81M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $438.61M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $430.72M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $428.06M 10-K · filed 2020-02-27 | |
| 2018-09-30 | $423.18M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $327.40M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $309.29M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $307.16M 10-K · filed 2019-03-12 | |
| 2017-09-30 | $305.17M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $302.92M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $300.15M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $212.87M 10-K · filed 2018-03-15 | |
| 2016-09-30 | $211.95M 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $211.18M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $210.48M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $209.94M 10-K · filed 2017-03-10 | |
| 2015-09-30 | $209.20M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $133.02M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $132.29M 10-Q · filed 2015-05-12 | |
| 2014-12-31 | $131.84M 10-K · filed 2016-03-11 | |
| 2013-12-31 | $8.38M 10-K · filed 2015-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |